QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=3941DE54353D3CDF1CE64D8A1232D6B1;jsessionid=D1FA22FAA8755B5C80CE0787C16AFDA1;jsessionid=0243B7E770E7D0A44065AE91FB30287D;jsessionid=7A9F1F741267961DE1EC5521805BD5C9;jsessionid=063B8D6EDF60000AD809184A3ADF121E;jsessionid=A3D5871C5F6EDEA522F141D9B44F103D (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII.

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=3941DE54353D3CDF1CE64D8A1232D6B1;jsessionid=D1FA22FAA8755B5C80CE0787C16AFDA1;jsessionid=0243B7E770E7D0A44065AE91FB30287D;jsessionid=7A9F1F741267961DE1EC5521805BD5C9;jsessionid=063B8D6EDF60000AD809184A3ADF121E;jsessionid=A3D5871C5F6EDEA522F141D9B44F103D